Gene · 3269
Papers3,179
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,179
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ectodomain shedding of EGFR ligands serves as an activation readout for TRP channels. | PLoS One | 2023 | 36668668 | PubTator, text mining | PubMed |
| A Par3/LIM Kinase/Cofilin Pathway Mediates Human Airway Smooth Muscle Relaxation by TAS2R14. | Am J Respir Cell Mol Biol | 2023 | 36662576 | PubTator, text mining | PubMed |
| Understanding neuroimmune interactions in disorders of gut-brain interaction: from functional to immune-mediated disorders. | Gut | 2023 | 36657961 | PubTator, text mining | PubMed |
| Diet-microbial cross-talk underlying increased visceral perception. | Gut Microbes | 2023 | 36656562 | PubTator, text mining | PubMed |
| Effects of Histamine and the α-Tocopherol Metabolite α-13'-COOH in an Atopic Dermatitis Full-Thickness Skin Model. | Molecules | 2023 | 36615633 | PubTator, text mining | PubMed |
| Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Levocetirizine Dihydrochloride. | J Pharm Sci | 2023 | 36581104 | PubTator, text mining | PubMed |
| Identification of Potential Biomarkers Using Integrative Approach: A Case Study of ESCC. | SN Comput Sci | 2023 | 36573207 | PubTator, text mining | PubMed |
| DNA methylation profile in the whole blood of acute coronary syndrome patients with aspirin resistance. | J Clin Lab Anal | 2023 | 36550638 | PubTator, text mining | PubMed |
| Design and synthesis of 2-(2,2-diarylethyl)-cyclamine derivatives as M3 receptor antagonists and functional evaluation on COPD. | Bioorg Chem | 2023 | 36516520 | PubTator, text mining | PubMed |
| Histamine bidirectionally regulates the intrinsic excitability of parvalbumin-positive neurons in the lateral globus pallidus and promotes motor behaviour. | Br J Pharmacol | 2023 | 36512485 | PubTator, text mining | PubMed |
| Pruritogens in pemphigoid diseases: Possible therapeutic targets for a burdensome symptom. | J Dermatol | 2023 | 36477831 | PubTator, text mining | PubMed |
| Connecting insufficient sleep and insomnia with metabolic dysfunction. | Ann N Y Acad Sci | 2023 | 36373239 | PubTator, text mining | PubMed |
| Anti-inflammatory effects of new human histamine H3 receptor ligands with flavonoid structure on BV-2 neuroinflammation. | Inflamm Res | 2023 | 36370200 | PubTator, text mining | PubMed |
| DNA methylation status of the SPHK1 and LTB genes underlies the clinicopathological diversity of non-alcoholic steatohepatitis-related hepatocellular carcinomas. | J Cancer Res Clin Oncol | 2023 | 36348017 | PubTator, text mining | PubMed |
| Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma. | Cancer Res | 2023 | 36318118 | PubTator, text mining | PubMed |
| Irritable bowel syndrome: treatment based on pathophysiology and biomarkers. | Gut | 2023 | 36307180 | PubTator, text mining | PubMed |
| The relationship of skin disorders, COVID-19, and the therapeutic potential of ginseng: a review. | J Ginseng Res | 2023 | 36249949 | PubTator, text mining | PubMed |
| Usefulness of Bifidobacterium longum BB536 in Elderly Individuals With Chronic Constipation: A Randomized Controlled Trial. | Am J Gastroenterol | 2023 | 36216361 | PubTator, text mining | PubMed |
| Evaluation of 147 perfluoroalkyl substances for immunotoxic and other (patho)physiological activities through phenotypic screening of human primary cells. | ALTEX | 2023 | 36129398 | PubTator, text mining | PubMed |
| In Vitro and In Vivo Comparative Analysis of Differentially Expressed Genes and Signaling Pathways in Breast Cancer Cells on Interaction with Mesenchymal Stem Cells. | Appl Biochem Biotechnol | 2023 | 36087230 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3269/papers?page=19